Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Mar-22 4:05 PM View:  | Korn Jerald COO & General Counsel | Kaleido Biosciences, Inc. (KLDO) | 28-Feb-22 | Payment of Exercise | 2,046 | $1.49 | $3,048.54 | (31%) 6.56K to 4.52K | |
| 02-Mar-22 4:09 PM View: | van Hylckama Vlieg Johan Chief Scientific Officer | Kaleido Biosciences, Inc. (KLDO) | 28-Feb-22 | Payment of Exercise | 2,087 | $1.49 | $3,109.63 | (31%) 6.71K to 4.62K | |
| 10-Feb-21 5:30 PM View: | Flagship Ventures Fund Iv G... 10% Owner | Kaleido Biosciences, Inc. (KLDO) | 08-Feb-21 | Market Purchase | 215,000 | $11.50 | $2,472,500.00 | 1% 19.36M to 19.58M | (2%) |
| 26-Feb-21 10:00 PM View: | Menichella Daniel L Chief Executive Officer Director | Kaleido Biosciences, Inc. (KLDO) | 08-Feb-21 | Market Purchase | 20,000 | $11.50 | $230,000.00 | 100% 0 to 20.0K | (17%) |
| 08-Jun-20 4:46 PM View: | Flagship Ventures Fund Iv G... 10% Owner | Kaleido Biosciences, Inc. (KLDO) | 04-Jun-20 | Market Purchase | 2,000,000 | $7.50 | $15,000,000.00 | 12% 17.36M to 19.36M | 24% |
| 05-Jun-20 4:06 PM View: | Melas Kyriazi Theo Director | Kaleido Biosciences, Inc. (KLDO) | 04-Jun-20 | Market Purchase | 33,333 | $7.50 | $249,998.00 | 100% 0 to 33.33K | 24% |
| 04-Mar-19 8:13 PM View: | Bonney Michael W Executive Chair Director | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 417,673 | -- | -- | 41% 1.01M to 1.43M | |
| 06-Mar-19 4:45 PM View: | Flagship Ventures Fund V Ge... Director 10% Owner | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 11,071,000 | -- | -- | 443% 2.5M to 13.57M | |
| 04-Mar-19 8:09 PM View: | von Maltzahn Geoffrey Director | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 342,466 | -- | -- | 100% 0 to 342.47K | |
| 04-Mar-19 8:13 PM View: | Bonney Michael W Executive Chair Director | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 225,000 | -- | -- | 16% 1.43M to 1.65M | |
| 06-Mar-19 4:45 PM View: | Flagship Ventures Fund V Ge... Director 10% Owner | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Purchase | 933,333 | $15.00 | $14,000,000.00 | 7% 13.57M to 14.5M | |
| 04-Mar-19 8:13 PM View: | Quinn Anthony Director | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 12,853 | -- | -- | 69% 18.75K to 31.6K | |
| 06-Mar-19 4:43 PM View: | Flagship Ventures Fund Iv G... Director 10% Owner | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 1,120,700 | -- | -- | 63% 1.78M to 2.9M | |
| 04-Mar-19 8:13 PM View: | Bonney Michael W Executive Chair Director | Kaleido Biosciences, Inc. (KLDO) | 28-Feb-19 | Purchase | 71,520 | $13.98 | $999,492.00 | 8% 937.0K to 1.01M |
